These findings suggest that rGLP-1 exposure may alter skin development at a molecular level, potentially affecting skin structure, pigmentation, and resilience
The FDA specifically stated that our preliminary evaluation has not found evidence that use of these medicines causes suicidal thoughts or actions while the MHRA noted that the available evidence does not establish a causal relationship between GLP-1 receptor agonists and suicidal behavior, suicidal ideation, self-injury and depression. Taken together, these formal investigations did not reveal evidence of a causal relationship between the use of GLP-1s and suicidal thoughts, self-injurious behavior, or even depression
Signs of low blood sugar include: Dizziness Headache Blurred vision Fast heartbeat Sweating Slurred speech Hunger Confusion Feeling jittery or irritable Shakiness Weakness If you start to notice signs of hypoglycemia, check your blood sugar
Avoid Trigger Foods: Limit spicy, fatty, or dairy-rich foods that may aggravate symptoms
.webp)
